| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |